Trials / Sponsors / Kwang Dong Pharmaceutical co., ltd.
Kwang Dong Pharmaceutical co., ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evalua Hypoactive Sexual Desire Disorder | Phase 3 | 2021-05-10 |
| Unknown | To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subj Obesity | Phase 1 | 2015-03-01 |
| Completed | A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injec Vitamin D Deficiency | Phase 3 | 2014-11-01 |
| Completed | A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramu Vitamin D Deficiency | Phase 4 | 2014-10-23 |
| Completed | Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subj Drug Toxicity | Phase 1 | 2013-12-01 |
| Completed | A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Place Overactive Bladder | Phase 2 | 2011-09-01 |